Works matching IS 00278874 AND DT 2023 AND VI 115 AND IP 7

Results: 10
    1

    Tucatinib promotes immune activation and synergizes with programmed cell death–1 and programmed cell death–ligand 1 inhibition in HER2-positive breast cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 7, p. 805, doi. 10.1093/jnci/djad072
    By:
    • Li, Ran;
    • Sant, Sneha;
    • Brown, Emmaline;
    • Caramia, Franco;
    • Nikolic, Bronte;
    • Clarke, Kylie;
    • Byrne, Ann;
    • Gonzalez, Luis E Lara;
    • Savas, Peter;
    • Luen, Stephen J;
    • Teo, Zhi Ling;
    • Virassamy, Balaji;
    • Neeson, Paul J;
    • Darcy, Phillip K;
    • Loi, Sherene
    Publication type:
    Article
    2
    3
    4

    Cancer mortality rates by racial and ethnic groups in the United States, 2018-2020.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 7, p. 822, doi. 10.1093/jnci/djad069
    By:
    • Haque, Anika T;
    • González, Amy Berrington de;
    • Chen, Yingxi;
    • Haozous, Emily A;
    • Inoue-Choi, Maki;
    • Lawrence, Wayne R;
    • McGee-Avila, Jennifer K;
    • Nápoles, Anna M;
    • Pérez-Stable, Eliseo J;
    • Taparra, Kekoa;
    • Vo, Jacqueline B;
    • Freedman, Neal D;
    • Shiels, Meredith S
    Publication type:
    Article
    5
    6

    Estimating human papillomavirus vaccine efficacy from a single-arm trial: proof-of-principle in the Costa Rica Vaccine Trial.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 7, p. 788, doi. 10.1093/jnci/djad064
    By:
    • Befano, Brian;
    • Campos, Nicole G;
    • Egemen, Didem;
    • Herrero, Rolando;
    • Schiffman, Mark;
    • Porras, Carolina;
    • Lowy, Douglas R;
    • Rodriguez, Ana Cecilia;
    • Schiller, John T;
    • Ocampo, Rebecca;
    • Hildesheim, Allan;
    • Sampson, Joshua N;
    • Das, Shrutikona;
    • Kreimer, Aimée R;
    • Cheung, Li C;
    • Group, for the Costa Rica HPV Vaccine Trial (CVT)
    Publication type:
    Article
    7
    8

    Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 7, p. 796, doi. 10.1093/jnci/djad061
    By:
    • Cantini, Luca;
    • Paoloni, Francesco;
    • Pecci, Federica;
    • Spagnolo, Francesco;
    • Genova, Carlo;
    • Tanda, Enrica Teresa;
    • Aerts, Sophie;
    • Rebuzzi, Sara Elena;
    • Fornarini, Giuseppe;
    • Zoratto, Federica;
    • Fancelli, Sara;
    • Lupi, Alessio;
    • Corte, Carminia Maria Della;
    • Parisi, Alessandro;
    • Bennati, Chiara;
    • Ortega, Cinzia;
    • Atzori, Francesco;
    • Piovano, Pier Luigi;
    • Orciuolo, Corrado;
    • Tursi, Michele De
    Publication type:
    Article
    9

    Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 7, p. 870, doi. 10.1093/jnci/djad046
    By:
    • Spencer, Kristen;
    • Pappas, Leontios;
    • Baiev, Islam;
    • Maurer, Jordan;
    • Bocobo, Andrea Grace;
    • Zhang, Karen;
    • Jain, Apurva;
    • Armas, Anaemy Danner De;
    • Reyes, Stephanie;
    • Le, Tri Minh;
    • Rahma, Osama E;
    • Stanton, Jennifer;
    • DeLeon, Thomas T;
    • Roth, Marc;
    • Peters, Mary Linton B;
    • Zhu, Andrew X;
    • Lennerz, Jochen K;
    • Iafrate, A John;
    • Boyhen, Kylie;
    • VanCott, Christine
    Publication type:
    Article
    10